2022 年 1 月 21 日 15:00(格林威治标准时间)
2022 年 1 月 21 日 16:30(格林威治标准时间)

Shocking societal challenges such as COVID-19, antimicrobial resistance, and pollution are forcing Big Pharma to overwork to produce drugs to sustain the increased demand. Although this is for the good, current unsustainable systems are toothless against the disregard of the harm caused by pollution and environmental antimicrobial agents leaks that produce deadly superbugs. This calls for the exploration of new rationales and processes of policy making such as transformative innovation policy (TIP) that have potential alternative socio-technical systems in the domains of health, environment, and agriculture. Kenya is currently assessing its pharmaceutical system’s potential for transformative change.

Current solutions to the problem of antimicrobial resistance such as antimicrobial stewardship programmes (ASPs) and “One Health” promote aspects of multidisciplinary and system level impact. However, most of these solutions, especially in countries of the global south, including Kenya operate under broken pharmaceutical regulatory systems. TIP can help to address such system failures that prevent the processes of transformative change. The Kenyan project hopes to interrogate key failures such as lack of directionality, wrongly directed demand articulation, lack of policy coordination and reflexivity failure among others. In this expression of interest, we propose to have a 15-20 minutes presentation on the quality improvement of antimicrobial stewardship programmes in the global south as well as the viability of One Health concept, followed by 60 minutes panel discussion session on challenges and opportunities of achieving One Health (animal and human health, environmental health and food and agricultural health) through lens of TIP.

Ref: #27



Frank Sawanga Ndakala holds a PhD in Tropical and Infectious Diseases from the University of Nairobi, and a Postgraduate Diploma in Translational Medicine from the University of Edinburgh, Scotland. He works as a research scientist and public policy advisor in the State Department of University Education and Research (SDUE&R), Ministry of Education (MoE) in Kenya. Also, he serves as director in the Laikipia University Council and as Principal Investigator for Pfizer supported Quality Improvement project on antimicrobial stewardship in Kenya. He has served for over 15 years at Senior Management positions in the Public and private sector. Furthermore, he has previously coordinated research and projects at national, regional, and international level including collaboration with the Science Policy Research Unit (SPRU), University of Sussex, UK on innovation studies. He has previously served in the Board of Management of 3 National Public Institutions and 2 University Councils.
Evelyn Wesangula 是一位拥有理学硕士学位的药剂师。热带和传染病,肯尼亚卫生部患者安全司的负责人,他从多部门的角度成功地支持了肯尼亚抗微生物药物耐药性国家政策和行动计划的制定以及相关战略的制定。作为国家联络人,她在国家层面实施感染预防和控制 (IPC) 干预措施、抗菌素耐药性 (AMR) 监测活动以及抗生素管理和意识计划方面发挥了关键作用。作为卫生部国家级感染预防和控制小组的成员,她指导了国家感染预防和控制指南的制定和实施以及卫生保健机构基本感染预防和控制的国家培训课程. Evelyn 领导 Covid-19 工作组中的 Covid-19 感染预防和控制工作流。她在肯尼亚卫生部工作了 10 多年。她曾担任世界卫生组织的顾问,制定有关建立和维持多部门合作的指南,以支持实施国家行动计划和最近的一项综合抗菌药物管理政策。她是查塔姆研究所研究员,目前正在数学建模和分析中心(CEMA,UON)和弗莱明基金政策研究员的帮助下攻读数学建模和分析奖学金。 Evelyn 致力于克服障碍,跨部门合作以维持变革,以减轻肯尼亚的 AMR 负担。
Dr Chux Daniels is a Research Fellow in Science, Technology and Innovation (STI) Policy at Science Policy Research Unit (SPRU), University of Sussex. His research connects STI and public policies in fostering transformative change that contributes to addressing development challenges. His areas of interest include STI, public policies, evaluation, inclusion in STI, capabilities of policymaking, entrepreneurship, indicators and metrics for STI. He is Director of the Transformative Innovation Africa Hub (TIAH) at the University of Pretoria and coordinates TIPC engagement with Africa members. His recent work on innovation policy, digitalisation, political economy, research and policy engagement programmes covers more than 10 African countries. Chux has delivered research and policy projects for major international and regional organisations including the African Union Commission (AUC), various national governments in Africa and beyond, DFID, IDRC, the UN, European Union, and the World Bank. Chux is a member AUC’s Monitoring and Evaluation Committee on the continent’s 10-year Science, Technology and Innovation Strategy for Africa (STISA-2024). He is a Visiting Fellow at the Graduate School of Technology Management (GSTM), Department of Engineering and Technology Management, University of Pretoria, South Africa; a Senior Fellow at the African Centre for Economic Transformation (ACET); and a Member of the UNESCO Chair in ICT4D (ICT for Development).